Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Immunosuppressive Tumor Microenvironment Status and Histological Grading of Endometrial Carcinoma.

Antomarchi J, Ambrosetti D, Cohen C, Delotte J, Chevallier A, Karimdjee-Soilihi B, Ngo-Mai M, Schmid-Alliana A, Schmid-Antomarchi H.

Cancer Microenviron. 2019 Dec;12(2-3):169-179. doi: 10.1007/s12307-019-00225-1. Epub 2019 May 27.

2.

Percutaneous vertebroplasty in tumoral spinal fractures with posterior vertebral wall involvement: Feasibility and safety.

Amoretti N, Diego P, Amélie P, Andreani O, Foti P, Schmid-Antomarchi H, Scimeca JC, Boileau P.

Eur J Radiol. 2018 Jul;104:38-42. doi: 10.1016/j.ejrad.2018.04.010. Epub 2018 Apr 20.

PMID:
29857864
3.

Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets.

Schmid-Alliana A, Schmid-Antomarchi H, Al-Sahlanee R, Lagadec P, Scimeca JC, Verron E.

Int J Mol Sci. 2018 Jan 4;19(1). pii: E148. doi: 10.3390/ijms19010148. Review.

4.

Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases.

Strazic-Geljic I, Guberovic I, Didak B, Schmid-Antomarchi H, Schmid-Alliana A, Boukhechba F, Bouler JM, Scimeca JC, Verron E.

Biochem Pharmacol. 2016 Sep 15;116:11-21. doi: 10.1016/j.bcp.2016.06.020. Epub 2016 Jul 1.

PMID:
27378505
5.

Adaptive immune response inhibits ectopic mature bone formation induced by BMSCs/BCP/plasma composite in immune-competent mice.

Bouvet-Gerbettaz S, Boukhechba F, Balaguer T, Schmid-Antomarchi H, Michiels JF, Scimeca JC, Rochet N.

Tissue Eng Part A. 2014 Nov;20(21-22):2950-62. doi: 10.1089/ten.TEA.2013.0633. Epub 2014 Jun 12.

PMID:
24785826
6.

Therapeutic strategies for treating osteolytic bone metastases.

Verron E, Schmid-Antomarchi H, Pascal-Mousselard H, Schmid-Alliana A, Scimeca JC, Bouler JM.

Drug Discov Today. 2014 Sep;19(9):1419-26. doi: 10.1016/j.drudis.2014.04.004. Epub 2014 Apr 14. Review.

PMID:
24742971
7.

CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma.

Cambien B, Richard-Fiardo P, Karimdjee BF, Martini V, Ferrua B, Pitard B, Schmid-Antomarchi H, Schmid-Alliana A.

PLoS One. 2011;6(12):e28842. doi: 10.1371/journal.pone.0028842. Epub 2011 Dec 20.

8.

Monocytes differentiation upon treatment with a peptide corresponding to the C-terminus of activated T cell-expressed Tirc7 protein.

Mouline CC, Beranger GE, Schmid-Antomarchi H, Quincey D, Momier D, Boukhechba F, Carle GF, Rochet N, Scimeca JC.

J Cell Physiol. 2012 Aug;227(8):3088-98. doi: 10.1002/jcp.23059.

PMID:
22015593
9.

Xg expression in Ewing's sarcoma is of prognostic value and contributes to tumor invasiveness.

Meynet O, Scotlandi K, Pradelli E, Manara MC, Colombo MP, Schmid-Antomarchi H, Picci P, Bernard A, Bernard G.

Cancer Res. 2010 May 1;70(9):3730-8. doi: 10.1158/0008-5472.CAN-09-2837. Epub 2010 Apr 13.

10.

Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs.

Pradelli E, Karimdjee-Soilihi B, Michiels JF, Ricci JE, Millet MA, Vandenbos F, Sullivan TJ, Collins TL, Johnson MG, Medina JC, Kleinerman ES, Schmid-Alliana A, Schmid-Antomarchi H.

Int J Cancer. 2009 Dec 1;125(11):2586-94. doi: 10.1002/ijc.24665.

11.

Silencing of hSlo potassium channels in human osteosarcoma cells promotes tumorigenesis.

Cambien B, Rezzonico R, Vitale S, Rouzaire-Dubois B, Dubois JM, Barthel R, Soilihi BK, Mograbi B, Schmid-Alliana A, Schmid-Antomarchi H.

Int J Cancer. 2008 Jul 15;123(2):365-371. doi: 10.1002/ijc.23511. Erratum in: Int J Cancer. 2008 Sep 15;123(6):1481. Soilihi, Babou Karimdjee [corrected to Karimdjee, Babou Soilihi].

12.
13.

Focal adhesion kinase pp125FAK interacts with the large conductance calcium-activated hSlo potassium channel in human osteoblasts: potential role in mechanotransduction.

Rezzonico R, Cayatte C, Bourget-Ponzio I, Romey G, Belhacene N, Loubat A, Rocchi S, Van Obberghen E, Girault JA, Rossi B, Schmid-Antomarchi H.

J Bone Miner Res. 2003 Oct;18(10):1863-71.

14.

The receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) is a new chemotactic factor for human monocytes.

Breuil V, Schmid-Antomarchi H, Schmid-Alliana A, Rezzonico R, Euller-Ziegler L, Rossi B.

FASEB J. 2003 Sep;17(12):1751-3. Epub 2003 Jul 18.

PMID:
12958198
15.

Prostaglandin E2 induces interaction between hSlo potassium channel and Syk tyrosine kinase in osteosarcoma cells.

Rezzonico R, Schmid-Alliana A, Romey G, Bourget-Ponzio I, Breuil V, Breittmayer V, Tartare-Deckert S, Rossi B, Schmid-Antomarchi H.

J Bone Miner Res. 2002 May;17(5):869-78.

Supplemental Content

Loading ...
Support Center